Want to join the conversation?
John Kreger of William Blair asks for an update on SIMPARICA. $ZTS said it expects SIMPARICA to be a key product in its portfolio and believes it will be an important platform to add new products into the parasiticide franchise. $ZTS expects this product to generate more than $100MM. Current market trends show a higher opportunity for SIMPARICA.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!